Skip to main content
Top

Going from Primary to Primordial Prevention: Is the Juice Worth the Squeeze?

  • 29-07-2024
  • Public Health Policy (SS Virani and D Mahtta, Section Editors)
Published in:

Abstract

Purpose of Review

While primary prevention strategies target individuals who are at high risk of cardiovascular disease, there is rising interest towards primordial prevention that focuses on preventing the development of risk factors upstream of disease detection. Therefore, we review the advantages of primordial prevention interventions on minimizing future cardiovascular events.

Recent Findings

Primordial prevention of atherosclerotic cardiovascular disease involves behavioral, genetic, and environmental strategies, starting from fetal/infant health and continuing throughout childhood and young adulthood. Early interventions focusing on modifiable risk factors such as physical inactivity, non-ideal body weight, smoking, and environmental pollutants are important towards preventing the initial occurrence of risk factors such as hypertension, dyslipidemia, and diabetes to ultimately reduce cardiovascular disease.

Summary

Implementing primordial prevention strategies early on in life can minimize cardiovascular events and lead to healthy aging in the population. Future studies can further evaluate the effectiveness of various primordial prevention strategies.
Title
Going from Primary to Primordial Prevention: Is the Juice Worth the Squeeze?
Authors
Andrew Chiou
Melody Hermel
Zohar Chai
Ariana Eiseman
Sheila Jeschke
Sandeep Mehta
Unab Khan
Zahra Hoodbhoy
Nilofer Safdar
Adeel Khoja
Vashma Junaid
Elizabeth Vaughan
Anwar T. Merchant
Junaid Iqbal
Aysha Almas
Salim S. Virani
Sana Sheikh
Publication date
29-07-2024
Publisher
Springer US
Published in
Current Cardiology Reports / Issue 10/2024
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-024-02109-3
This content is only visible if you are logged in and have the appropriate permissions.

Next-generation MRI contrast agents: preparing the field (Link opens in a new window)

New MRI contrast agents are reshaping diagnostic imaging, promising lower gadolinium exposure amid evolving practice guidelines. How can you optimise contrast selection, dosing, and patient care in this rapidly advancing field?

This content is intended for healthcare professionals outside of the UK.

Independent Medical Education Grant:
  • Bayer HealthCare Pharmaceuticals Inc.
Learn more Link opens in a new window
Image Credits
Abstract graphic of layered, concentric circular shapes in bright green, pink, blue, and purple on a dark blue background. The rings and segments form a complex radial pattern without text/© Springer Health+ IME